MAIMONIDES MEDICAL CENTER — History
CCN 330194 | 3-year financial timeline | COVID resilience: 83/100
🛡️ Public data only — no PHI permitted on this instance.
$1.2B
Latest Revenue (FY2022)
+14.5%
Revenue CAGR (3yr)
-26.5%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $915M | $952M | $1.2B | +26.0% | +14.5% |
| Operating Expenses | $1.4B | $1.4B | $1.5B | +6.5% | +4.8% |
| Operating Margin | -51.2% | -49.7% | -26.5% | +46.7% | +0.0% |
| Net Income | $-468M | $-474M | $-318M | +32.9% | +0.0% |
| Licensed Beds | 641 | 641 | 641 | +0.0% | +0.0% |
| Total Patient Days | 173,349 | 181,884 | 171,819 | -5.5% | -0.4% |
| Medicare Day % | 30% | 30% | 30% | -1.3% | -0.0% |
| Medicaid Day % | 9% | 7% | 7% | -0.5% | -11.1% |
COVID Impact & Recovery
Resilience Score: 83/100 — Resilient — strong COVID recovery
Revenue recovery from FY2020 to FY2022: +31.2% ($915M → $1.2B)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+14.5%
This Hospital
+7.6%
State Avg
Latest Margin
-26.5%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $1.3B | -14.1% |
| FY2024 (proj) | $1.5B | -1.8% |
| FY2025 (proj) | $1.6B | 10.5% |